ArchiMed bought Natus Medical Natus Medical from 7/21/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

ArchiMed completed its acquisition of Natus Medical for $1.2 billion, or $33.5 per share.

Natus Medical

Review

Source:

{source} pictogram

investor.natus.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Ozon Pharmaceuticals recommended that dividends be paid for 2024

4/29/25 OZPH

Board of Directors of IMCB recommended that dividends be paid for 2024

4/29/25 GEMA

Henderson reported for January through March 2025

4/29/25 HNFG

EuroTrans reports for 2024 under RAS

4/29/25 EUTR

Yandex began developing software for humanoid robots

4/29/25 YDEX

Rosseti Tomsk reported for 3 months of 2025 by RAS

4/29/25 TORS

EuroTrans reports for 2024 by IFRS

4/29/25 EUTR

Globaltrak reported for 2024 by IFRS

4/29/25 GTRK

X5 Group launches online storefronts on Ozon

4/29/25 X5

Permenergosbyt reported for 3 months of 2025 by RAS

4/29/25 PMSB